News

Bildnachweis: neoplas med, WITENO, neoplas med. neoplas med GmbH from Greifswald, Germany, is considered a pioneer in medical ...
Bildnachweis: AVEGA Capital Management. Observers of the political landscape in Germany saw a glimpse of light last year: ...
Bildnachweis: PwC. For corporations seeking to maintain a competitive edge and corporate venture capital (CVC) arms striving ...
Bildnachweis: Life Science Factory, Avocet Bio, VC Magazin, Pixabay. The Life Science Factory offers founders from research ...
Bildnachweis: ITM Isotope Technologies Munich SE, VC Magazin, Pixabay. As the global demand for targeted cancer therapies ...
Bildnachweis: BIO Deutschland, BioM, EY, BCG, Biomed X, VC Magazin, Pixabay. In principle, Germany has excellent prerequisites, but does not currently play a leading role internationally in the life ...
Germany’s start-ups are off to a great start in 2025. As per the KfW Venture Capital Dashboard, high-potential German ventures raked in EUR 1.6 billion in funding in Q1 2025 – a 14% jump from the ...
There are many uncertainties in the world, but this much is certain: the demand for innovative life sciences solutions will continue to grow, from research to therapy development. Despite regulatory ...
For everyone who likes obscure abbreviations, sustainability regulations these days are a gold mine. NFRD, SFDR, CSRD, ESRS, TCFD — name a four-letter abbreviation and there’s a fair chance some ...
Xue Huang has worked for well-known start-up unicorns such as Uber and Mobike in China, as well as with start-up founders across various industries for over a decade before moving to Australia. She ...
The IPO of young, innovative growth companies in Germany has hardly been successful to date, as the associated cost, publicity and transparency requirements still place a heavy burden on them. With ...
The current environment is one of increased regulation and scrutiny, which has led to increased pressure on firms’ CFOs and COOs to manage their risks more effectively. This posed many interesting ...